Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness
Guardado en:
Autores principales: | Nita Jha, Sameer Kumta, Puneet Dewan, Nimalan Arinaminpathy, Arindam Nandi, Sreenivas A Nair, Raghuram Rao, Kuldeep S Sachdeva, Kiran Rade, Shibu Vijayan, Bhavin Vadera |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a439efbc804f46d1b737fc9803acd6b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TRANSACTION COSTS OF THE CONCESSION AGREEMENT AS FORMS OF STATE-PRIVATE PARTNERSHIP
por: A. Boldyrev
Publicado: (2017) -
Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010.
por: Kuldeep Singh Sachdeva, et al.
Publicado: (2011) -
The Cost of Carbon Stored on Afforested Lands in the Southern United States
por: Madisen Fuller, et al.
Publicado: (2021) -
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
por: Neeraj Raizada, et al.
Publicado: (2014) -
Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India
por: Sandip Mandal, et al.
Publicado: (2021)